Vimarsana
Biggest News Aggregation in the World

Page 10 - Scott Struthers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scott Struthers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scott Struthers Today - Breaking & Trending Today

Crinetics Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Vimarsana News

Crinetics Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

12.08.2022 - Paltusotine’s Phase 3 PATHFNDR Program in Acromegaly and Phase 2 Program in Carcinoid Syndrome Remain on Track for Top-Line Data in 2023 CRN04894 Phase 1 Data Demonstrated Pharmacologic Proof-of-Concept for Further Development in Both Cushing’s ...

Malawi's wildlife completes 263 elephants translocation from Liwonde to Kasungu National Park - Malawi Nyasa Times - Vimarsana News

Malawi's wildlife completes 263 elephants translocation from Liwonde to Kasungu National Park - Malawi Nyasa Times

Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Consensus Recommendation of "Buy" from Analysts - Vimarsana News

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Consensus Recommendation of "Buy" from Analysts

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Rating) has been given a consensus rating of “Buy” by the eight analysts that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target among analysts that […]

Short Interest in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Drops By 18.0% - Vimarsana News

Short Interest in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Drops By 18.0%

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Rating) saw a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 2,180,000 shares, a drop of 18.0% from the April 15th total of 2,660,000 shares. Based on an average daily volume of 277,300 shares, the days-to-cover ratio is […]

Crinetics Pharmaceuticals Reports First Quarter 2022 - Vimarsana News

Crinetics Pharmaceuticals Reports First Quarter 2022

Phase 1 Multiple-Ascending Dose Data for CRN04894 Expected in 2Q22 Paltusotine’s Phase 3 PATHFNDR Trials in Acromegaly Advancing Towards Anticipated...